| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94546a5a88b56b523e9c8917fad11e98 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 |
| filingDate |
2013-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c36a5840b4c2ed7662a851f0319a059d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ba7cbdc99a1243f88ff92c13ec8a1ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2f4ab8d4ea2dd2a6f618e4db22bb245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d704a7c471d90930ee097da5acbbf9a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1cc66158d41e7f33565babc8d1bf49c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab30c9d780c557da846b21628423b9bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a7c98edf942d07b50432f3861ab4a63 |
| publicationDate |
2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20170082657-A |
| titleOfInvention |
Anti-Mycoplasma Spp. Subunit Vaccine |
| abstract |
The present invention provides proteins suitable for use as an active ingredient in sub-unit vaccines against mycoplasma spp. The present invention also provides subunit vaccines prepared therefrom. The protein has been experimentally proven to have the ability to induce a sufficient immune response to avoid infection with mycoplasma species. The vaccine may have one of the proteins as an active ingredient or may have two or more of the proteins and be formulated as a cocktail vaccine. The vaccines of the present invention are not only more stable than conventional vaccines, but also have the same or better immune effect. |
| priorityDate |
2013-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |